Technical Analysis for CRSP - CRISPR Therapeutics AG

Grade Last Price % Change Price Change
F 120.305 5.17% 5.92
CRSP closed down 1.17 percent on Monday, April 12, 2021, on 53 percent of normal volume.
Earnings due: Apr 26
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Down Flat
Historical CRSP trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 2.31%
NR7 Range Contraction -1.63%
Multiple of Ten Bullish Other -1.63%
20 DMA Resistance Bearish -0.10%
Multiple of Ten Bearish Other -0.10%
20 DMA Resistance Bearish -2.64%
Multiple of Ten Bullish Other -2.64%
Outside Day Range Expansion -2.64%
20 DMA Resistance Bearish -2.93%
NR7 Range Contraction -2.93%
Older End-of-Day Signals for CRSP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 5 minutes ago
Up 5% 5 minutes ago
200 DMA Resistance about 4 hours ago
10 DMA Resistance about 4 hours ago
Rose Above 10 DMA about 5 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering DNA CRISPR Genome Editing Cas9

Is CRSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 220.15
52 Week Low 46.01
Average Volume 2,030,581
200-Day Moving Average 117.92
50-Day Moving Average 134.91
20-Day Moving Average 121.46
10-Day Moving Average 117.98
Average True Range 7.92
ADX 21.75
+DI 16.14
-DI 24.60
Chandelier Exit (Long, 3 ATRs ) 113.24
Chandelier Exit (Short, 3 ATRs ) 130.26
Upper Bollinger Band 135.54
Lower Bollinger Band 107.38
Percent B (%b) 0.25
BandWidth 23.18
MACD Line -4.75
MACD Signal Line -5.43
MACD Histogram 0.6806
Fundamentals Value
Market Cap 8.08 Billion
Num Shares 70.7 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 361.99
Price-to-Sales 92.44
Price-to-Book 5.79
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 121.50
Resistance 3 (R3) 121.28 118.69 120.32
Resistance 2 (R2) 118.69 116.88 118.80 119.92
Resistance 1 (R1) 116.54 115.76 115.24 116.76 119.53
Pivot Point 113.94 113.94 113.30 114.06 113.94
Support 1 (S1) 111.80 112.13 110.50 112.02 109.25
Support 2 (S2) 109.20 111.01 109.31 108.86
Support 3 (S3) 107.05 109.20 108.46
Support 4 (S4) 107.28